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Abstract 7 
Households in rural locations utilize septic tanks for wastewater treatment and can cause surface 8 
water contamination. A new methodology was developed to help investigate the role septic tanks play 9 
in the dissemination of prescription and over-the-counter drugs, personal care products and stimulants 10 
in the aqueous environment. Simultaneous analysis of 16 chiral and achiral anthropogenic markers 11 
was achieved using a Chirobiotic V2® enantioselective column in polar ionic mode. The optimized 12 
method achieved quantitation limits for 16 compounds in the range 0.001-2.9 µg L-1 and 0.0002-0.43 13 
µg L-1 for septic tank effluent and stream water, respectively. Application of the method to samples 14 
collected in North East Scotland found caffeine to be ubiquitous in all samples studied suggesting it as 15 
a good indicator of septic tank discharge. In rural streams studied, concentrations of all prescription 16 
drugs investigated were ≤0.02 µg L-1. However, analgesics and stimulants were at high concentration 17 
in one location indicating direct discharge of septic tank wastewater (i.e., not dissipated through a 18 
soak away). For example, paracetamol, cotinine and caffeine were measured at 1,100 µg L-1, 31 µg L-1 19 
and 200 µg L-1, respectively, which is comparable to septic tank effluents. Furthermore, S(+)-20 
amphetamine and R(-)-amphetamine were present in this stream sample at 0.20 and 0.27 µg L-1. This 21 
corresponds to an enantiomeric fraction of 0.43, which is typical of untreated wastewaters in the UK. 22 
Findings illustrate further study on the diffuse impact of septic tanks to surface water is needed and 23 
can be supported using this new multi-residue enantioselective method. 24 
 25 
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1. Introduction 27 
Anthropogenic chemicals such as pharmaceuticals and personal care products are ubiquitous in 28 
surface waters receiving municipal wastewater discharges (Hughes et al., 2013; Petrie et al., 2015).  29 
The presence of anthropogenic chemicals in surface waters is concerning due to their pharmacological 30 
active nature and the possible detrimental impact to aquatic organisms (Kasprzyk-Hordern, 2010; 31 
Hughes et al., 2013).  The majority of research to date has focused on the impact of effluent 32 
discharges from communal wastewater treatment plants (WWTPs) (Nakada et al., 2006; Gardner et 33 
al., 2012; Baker and Kasprzyk-Hordern et al., 2013; Archer et al., 2017).  However, a notable portion 34 
of the population can be served by onsite wastewater treatment processes such as septic tanks.  It is 35 
estimated that such systems (or similar) serve 20 % of households in the United States (Schaider et al., 36 
2017) and 33 % in Ireland (Carlow Tanks, 2018).  In Scotland, there are 161,000 known private 37 
wastewater discharges (CREW, 2018).  Assuming an average number of inhabitants per household of 38 
2.16 (National Records of Scotland, 2018), this would equate to a conservative estimate of 7 % of the 39 
Scottish population using a septic tank. 40 
Septic tank systems consist of a concrete or plastic chamber which allows settling of solids and 41 
flotation of fat, oil and grease.  It is considered that wastewater needs retained within the tank for a 42 
minimum of 24 h to pass through the system at slow velocity and turbulence for treatment (Seabloom 43 
et al., 2005).  The anaerobic environment facilitates slow growing bacteria which decompose organic 44 
matter.  However, solids enter the tank at a faster rate than they are broken down.  Therefore it is 45 
recommended that septic tanks need emptied every 1-2 years (Carlow Tanks, 2018).  The quality of 46 
septic tank effluent is considerably poorer than that of conventional (aerobic) communal WWTPs 47 
such as trickling filters.  For further treatment the effluent typically enters a soak away/septic drain 48 
field and is dissipated in the environment (Schaider et al., 2017).  This can lead to the contamination 49 
of ground water and surface water with anthropogenic chemicals such as pharmaceuticals (Schaider et 50 
al., 2017).  The potential for contamination of water bodies by septic systems can be increased by 51 
poor tank maintenance.  Furthermore, septic tanks are often historical systems with little knowledge 52 
on their configuration or maintenance history.   53 
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Septic tanks are not designed for the removal of trace contaminants.  Consequently, effluents from 54 
septic tanks have previously been found to contain prescription drugs, over-the-counter drugs, 55 
stimulants, personal care products and their metabolites (Hinkle et al., 2005; Carrara et al., 2008; 56 
Conn et al., 2010; Phillips et al., 2015; Schaider et al., 2017).  Such compounds (which do not have 57 
veterinary uses) are useful indicators of septic tank discharge entering both ground and surface waters.  58 
In septic tank effluent these markers vary in concentration from a few ng L-1 to mg L-1 and their fate 59 
and removal in drain fields can vary greatly (Schaider et al., 2017).  The majority of research to date 60 
has focused on the influence of septic tank discharges to ground water and drinking water quality 61 
(Hinkle et al., 2005; Swartz et al., 2006; Godfrey et al., 2007; Phillips et al., 2015; Schaider et al., 62 
2016).  However, septic tanks can be located close to small streams which form sub-catchments of 63 
larger rivers.  These small streams are themselves important ecosystems and can be used to help 64 
estimate the contribution of septic tanks to riverine concentrations of anthropogenic chemicals.  65 
Nevertheless, information on the impact of septic tanks to rural surface water quality is scarce.     66 
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is preferred for analysis of 67 
pharmaceuticals and related chemicals in the environment due to its excellent sensitivity and 68 
specificity.  It is recommended that analysis of chiral anthropogenic chemicals is undertaken at the 69 
enantiomeric level (Kasprzyk-Hordern, 2010; Sanganyado et al., 2017).  This is essential for risk 70 
assessment due to enantiospecific toxicity of chiral species (Stanley et al., 2006; 2007; De Andrés et 71 
al., 2009).  For example, R(-)-fluoxetine is approximately 30 times more toxic than S(+)-fluoxetine 72 
towards Tetrahymena thermophila (De Andrés et al., 2009).  Furthermore, investigating the 73 
enantiomeric distribution of chiral analytes helps understand their source, fate and transport in the 74 
water cycle (Bagnall et al., 2013; Emke et al., 2014; Petrie et al., 2016a).  This is because chiral 75 
analytes can undergo (varying degrees of) stereoselective metabolism within the human body, during 76 
wastewater treatment and in the environment itself.  Nevertheless, there is a general lack of 77 
enantioselective methods in the literature for environmental analysis.  It is important that 78 
enantioselective methods support the simultaneous determination of achiral anthropogenic markers 79 
for a holistic understanding of water quality with respect to these chemicals.  Existing methods that 80 
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measure anthropogenic chemicals in wastewaters and surface waters do not support multi-residue 81 
enantioseparations and achiral analyte determinations (Bagnall et al., 2012; Lopez-Serna et al., 2013; 82 
Zhao et al., 2016) or have chromatographic run times (e.g., >60 min) (Lopez-Serna et al., 2013; 83 
Camacho-Muñoz and Kasprzyk-Hordern, 2015; Camacho-Muñoz and Kasprzyk-Hordern, 2017).  84 
Therefore, the aim of the study was to develop a new analytical methodology (including sample 85 
storage, extraction and instrumental analysis) for the multi-residue determination of chiral and achiral 86 
anthropogenic markers of septic tank discharge in a run time <60 min.  A total of 16 anthropogenic 87 
markers (over-the-counter medication, prescription drugs, stimulants and personal care products) were 88 
analysed simultaneously by LC-MS/MS using a Chirobiotic V2® enantioselective column.  The 89 
developed method was applied to septic tank effluents and surface waters in North East Scotland.    90 
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2. Materials and methods 91 
2.1. Materials 92 
The analytical standards aspartame, methylparaben, triclocarban, caffeine, carbamazepine, 93 
carbamazepine 10,11 epoxide, cotinine, paracetamol, R/S(±)-amphetamine, R/S(±)-atenolol, R/S(±)-94 
chlorpheniramine, R/S(±)-citalopram, R/S(±)-fluoxetine, R/S(±)-MDMA, R/S(±)-propranolol and 95 
R/S(±)-salbutamol were purchased from Sigma-Aldrich (Gillingham, UK) as well as the following 96 
labelled surrogate standards: caffeine-13C3, carbamazepine-d10, carbamazepine 10,11 epoxide-d10, 97 
cotinine-d3, paracetamol-d4, triclocarban-d3, R/S(±)-amphetamine-d11, R/S(±)-atenolol-d7, R/S(±)-98 
chlorpheniramine-d6, R/S(±)-citalopram-d6, R/S(±)-fluoxetine-d6, R/S(±)-MDMA-d5, R/S(±)-99 
propranolol-d7 and R/S(±)-salbutamol-d3. Oasis HLB (60mg, 3mL) cartridges for solid phase 100 
extraction (SPE) were obtained from Waters (Manchester, UK). HPLC-grade methanol, ammonium 101 
acetate and acetic acid were purchased from Fisher Scientific (Loughborough, UK).  Ultra-pure water 102 
used throughout the study was of 18.2 MΩ cm-1 quality.  For method development and validation, 103 
effluent (5 L) was collected from a septic tank which serves 7 inhabitants in Aberdeenshire, North 104 
East Scotland.  Stream water (10 L) was collected from a tributary of the River Don, Aberdeenshire.  105 
2.2. Sample collection and solid phase extraction 106 
All samples were collected (1 L for septic tank effluent and surface water) and transported in 107 
polypropylene bottles (Petrie et al., 2017).  These were kept dark and cooled to 4 ˚C whilst 108 
transported to the laboratory for processing.  Firstly, septic tank effluent and stream samples were 109 
filtered through 0.7 µm GF/F filters (Fisher Scientific).  Aliquots of 25 mL effluent and 250 mL 110 
stream water were then spiked with 100 ng of all deuterated surrogates (100 µL of a 1,000 µg L-1 111 
methanolic mixture).  For SPE, Oasis HLB cartridges were conditioned with 2 mL methanol and 112 
equilibrated with 2 mL water under gravity at a rate of 1 mL min-1.  Effluent and stream water were 113 
then loaded at 5 mL min-1, washed with 10 mL water and dried. 4 mL methanol was subsequently 114 
used to elute analytes under gravity at 1 mL min-1 which were accordingly dried using nitrogen stream 115 
at 40 °C.  Dried residues were reconstituted in 250 µL mobile phase (methanol containing 1 mM 116 
ammonium acetate and 0.01 % acetic acid) and filtered through 0.2 µm LC-MS pre-filters ready for 117 
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enantioselective LC-MS/MS analysis.  All samples were prepared in triplicate and analysed within 24 118 
h of collection.  Prepared samples containing anthropogenic markers above their respective calibration 119 
ranges were appropriately diluted and re-analyzed.   120 
2.3. Enantioselective LC-MS/MS 121 
An Agilent 1200 Infinity Series HPLC coupled to a 6420 MS/MS triple quadrupole (Cheshire, UK) 122 
was used for analysis.  Separation was performed using a Chirobiotic V2® HPLC column (250 x 2.1 123 
mm; 5 µm) maintained at 15 °C.  The final mobile phase was methanol containing 1 mM ammonium 124 
acetate and 0.01 % acetic acid.  This was operated under isocratic conditions with a flow rate of 0.17 125 
mL min-1.  The injection volume was 40 µL and run time 55 min.  126 
Electrospray ionisation (ESI) in both positive and negative modes with a capillary voltage of 4,000 V 127 
was used.  Nitrogen was the nebulising, desolvation and collision gas.  The desolvation temperature 128 
was 350 °C with a gas flow of 12 L min-1.  The nebulizing pressure was 50 psi.  All analytes were 129 
analysed in positive mode except methylparaben, triclocarban and triclocarban-d3 which were 130 
analysed in negative mode.  Optimized multiple reaction monitoring (MRM) transitions for each 131 
analyte are compiled in Table S1.   132 
2.4. Instrument and method performance 133 
A 13-point calibration curve ranging in concentration from 0 to 5,000 µg L-1 was used to establish 134 
linearity.  For chiral analytes this represents their total enantiomeric concentration (i.e., 5,000 µg L-1 is 135 
equivalent to 2,500 µg L-1 of each enantiomer).  To determine intra- and inter-day precision and 136 
accuracy, triplicate injections of 10, 100 and 500 µg L-1 standards were, respectively, conducted 137 
within 24 h and over 3 different days.  Instrument detection limits (IDLs) were determined by the 138 
lowest concentration at which the signal-to-noise ratio (S/N) ≥3 and instrument quantitation limit 139 
(IQL) when S/N ≥10.  Sensitivity of the SPE-enantioselective LC-MS/MS method was determined by 140 
calculating the method detection limit (MDL) and method quantitation limit (MQL) for each analyte: 141 
𝑀𝑀𝑀𝑀𝑀𝑀 (𝜇𝜇𝜇𝜇 𝑀𝑀−1) = 𝐼𝐼𝐼𝐼𝐼𝐼 𝑥𝑥 100
𝑅𝑅𝑅𝑅𝑅𝑅 𝑥𝑥 𝐶𝐶𝐶𝐶          [1] 142 
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𝑀𝑀𝑀𝑀𝑀𝑀 (𝜇𝜇𝜇𝜇 𝑀𝑀−1) = 𝐼𝐼𝐼𝐼𝐼𝐼 𝑥𝑥 100
𝑅𝑅𝑅𝑅𝑅𝑅 𝑥𝑥 𝐶𝐶𝐶𝐶          [2] 143 
Here IDL and IQL are the instrumental detection and quantitation limits, respectively (µg L-1), Rec is 144 
the absolute analyte recovery (%) and CF is the pre-concentration factor (100 for effluent and 1,000 145 
for stream water). 146 
During the development stages the optimum concentration factor for SPE was determined for both 147 
septic tank effluent and stream water samples.  This involved spiking filtered effluent and stream 148 
water with an additional 1 µg L-1 of each anthropogenic marker.  Concentration factors investigated 149 
were 25, 50, 100, 250 and 500 for effluent and 100, 250, 500, 1,000 and 2,000 for stream water. 150 
Method recovery was established by spiking filtered environmental samples at two concentration 151 
levels.  Effluent was spiked at 0.5 µg L-1 and 5 µg L-1 whereas stream water was spiked at 0.05 and 152 
0.5 µg L-1.  Signal suppression caused by co-extracted matrix was assessed by extracting samples as 153 
described previously and spiking SPE extracts to achieve a final theoretical concentration of 200 µg L-154 
1.  The suppression of analyte signal intensity using the developed SPE method was quantified using 155 
the following equation: 156 
𝑆𝑆𝑆𝑆𝜇𝜇𝑆𝑆𝑆𝑆𝑆𝑆 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑆𝑆𝑠𝑠𝑆𝑆 (%) = 100 − �(𝐴𝐴 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑅𝑅𝑠𝑠 𝑅𝑅𝑥𝑥𝑒𝑒𝑒𝑒𝑒𝑒𝑅𝑅𝑒𝑒−𝐴𝐴 𝑢𝑢𝑢𝑢𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑅𝑅𝑠𝑠 𝑅𝑅𝑥𝑥𝑒𝑒𝑒𝑒𝑒𝑒𝑅𝑅𝑒𝑒)
𝐴𝐴 𝑠𝑠𝑒𝑒𝑒𝑒𝑢𝑢𝑠𝑠𝑒𝑒𝑒𝑒𝑠𝑠 𝑥𝑥 100�   [3] 157 
Where A spiked extract is the peak area of analyte in extracts spiked post-SPE, A unspiked extract is 158 
the peak area of analyte in extracts not spiked and A standard is the peak area of analyte in a standard 159 
solution which corresponds to the spike.  All analysis was performed in triplicate. 160 
2.5. Anthropogenic marker stability in collected samples 161 
The stability of analytes was assessed under typical sample transport/storage conditions.  Both freshly 162 
collected septic tank effluent and stream water were spiked to ensure adequate levels of all 163 
anthropogenic markers for detection (5 µg L-1 and 0.5 µg L-1, respectively), and mixed.  Sample 164 
volumes of 4 L were prepared in polypropylene bottles and stored in the dark at both room 165 
temperature (18 ±0.5 ˚C) and 4 ±0.5 ˚C (Petrie et al., 2017).  Bottles were then left unmixed to 166 
replicate proposed storage conditions.  Samples were then taken for analysis and subject to SPE as 167 
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described previously at 0, 6, 24 and 48 h.  The enantiomeric composition (and changes) of chiral 168 
markers can be expressed as enantiomeric fraction (EF) using: 169 
𝐸𝐸𝐸𝐸 = (+)[(+)+(−)]                [4] 170 
Here (+) is the concentration of the (+)-enantiomer and (-) is the concentration of the (-)-enantiomer.   171 
2.6. Profiling anthropogenic markers in septic tank effluents and surface waters 172 
Two sub-catchments of the River Don, Aberdeenshire were investigated (Figure 1).  These were 173 
studied as they are rural areas without communal wastewater discharges within their catchment area. 174 
The land use of both catchments is arable farmland.  Any wastewater discharges here are from septic 175 
tanks or farmyards.  Sub-catchment A contains ~10 septic tanks (estimated population of 30 176 
inhabitants) and a small stream (discharge <0.1 m3 s-1).  Sub-catchment B (Figure 1) contains >100 177 
septic tanks with a population of ~500 inhabitants and a stream with an estimated discharge of ~0.1 178 
m3 s-1.  Permission was granted to sample effluent from 15 septic tanks (Figure 1).  All septic tanks 179 
were constructed of concrete serving 2-7 inhabitants per tank.  A total of 11 stream water samples 180 
were collected from sub-catchments A and B.  The River Don is impacted by communal wastewater 181 
discharges as well as effluent from septic tanks and farmyards.  River water was collected upstream 182 
and downstream of each sub-catchment location (Figure 1), and at the time of sampling the river 183 
discharge was 9.5 m3 s-1.  The nearest communal WWTP discharge is 7 km upstream of sampling 184 
point 1 (Figure 1).  Sampling was conducted on 21st June 2018.       185 
  186 
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3. Results and discussion 187 
3.1. Instrumental development and performance 188 
A Chirobiotic V2® enantioselective column was operated in polar ionic mode due to its separation 189 
ability for a range of chiral anthropogenic markers at the enantiomeric level including beta-blockers, 190 
beta-agonists, anti-depressants, stimulants and anti-histamines.  The mobile phase consisted of 1 mM 191 
ammonium acetate in methanol containing 0.01 % acetic acid maintained at 0.17 mL min-1.  It was 192 
found that ammonium acetate concentration and column temperature had the greatest influence on 193 
enantioseparations.  Reduced mobile phase concentrations of ammonium acetate improved 194 
enantioresolution (RS), however this can lead to reduction in ionization and MS/MS sensitivity for 195 
some analytes.  The final method utilized a concentration of 1 mM ammonium acetate which gave the 196 
best trade-off between RS and sensitivity for the analytes studied.   197 
Reducing column temperature improved enantiomer separation for the majority of chiral analytes.  198 
This is in agreement with Sanganyado et al (2014) who noted that reducing column temperature from 199 
40 ˚C to 13 ˚C improved RS of both atenolol and fluoxetine enantiomers under similar mobile phase 200 
conditions.  In our study the column temperature was maintained at 15 ˚C which facilitated 201 
satisfactory multi-residue enantiomeric separation within a run time of 55 min.  RS was ≥1 for all 202 
chiral anthropogenic markers which showed separation (atenolol, propranolol, salbutamol, fluoxetine, 203 
citalopram, amphetamine and chlorpheniramine) (Figure 2).  This satisfies a maximum 2 % peak 204 
overlap required for quantitative analysis (Bagnall et al., 2012).  Under these conditions achiral 205 
analytes (caffeine, paracetamol, etc) were also determined.  Achiral analytes exhibited retention times 206 
between 5 and 10 min due to comparatively less interaction with the chiral vancomycin stationary 207 
phase (Figure 2).  Nevertheless, peak shape was satisfactory avoiding the need for a separate non-208 
chiral analytical method to encompass a full suite of anthropogenic markers.    209 
Instrument performance for all chiral and achiral analytes was evaluated by investigating linearity, 210 
sensitivity and intra- and inter-day precision and accuracy.  The majority of analytes exhibited 211 
linearity from their respective IQL to 1,000 or 2,500 µg L-1 with coefficient of determination (r2) 212 
≥0.999 (Table S2).  IDLs were in the range 0.02-1.5 µg L-1 and IQLs 0.05-10 µg L-1.  Only aspartame 213 
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was out with these ranges due to broad peak shape.  Intra- and inter-day precision was generally <5 % 214 
whereas accuracy was normally ±10 % for each concentration level studied (Table S3).  The 215 
instrument performance was similar to previously reported enantioselective vancomycin methods 216 
operated in polar ionic mode by LC-MS/MS for both chiral analytes (López-Serna et al., 2013; Evans 217 
et al., 2015; Petrie et al., 2018) and achiral analytes (Petrie et al., 2018).   218 
3.2. Extraction and method performance 219 
Oasis HLB cartridges were selected for SPE as they are favoured for multi-residue analysis due to the 220 
mixed mode ion exchange and reversed phase retention mechanisms of the co-polymer.  Furthermore, 221 
extracted samples do not require elution with any additive (e.g., ammonium hydroxide) which can be 222 
detrimental to enantioselective separation on vancomycin stationary phases (Evans et al., 2015; Petrie 223 
et al., 2018).  However, a drawback of using non-selective SPE is the comparatively high 224 
concentration of co-extractives in environmental samples containing the analyte of interest.  This can 225 
lead to severe quenching (or complete loss) of analyte signal strength during ESI (Gros et al., 2006).  226 
Extracting more analyte at greater sample pre-concentration factors may not be translated into 227 
increased instrument response.  A breakthrough can be reached where signal suppression outweighs 228 
the advantages of extracting a greater quantity of analyte (as well as sorbent saturation).   Therefore, it 229 
is essential to investigate the sample pre-concentration factor which gives the highest analyte 230 
response, especially when conducting environmental trace analysis.   231 
For septic tank effluent, pre-concentration factors of 25, 50, 100, 250 and 500 were investigated.  It 232 
was found that analyte response increased proportionally with concentration factors up to 100 (Figure 233 
S1).  Above this value, response did not increase for some analytes (particularly those with retention 234 
times <30 min) and loss of chiral recognition was observed.  Therefore, the pre-concentration factor 235 
selected for effluent was 100.  In stream water analyte response increased linearly over the studied 236 
range of pre-concentration factors investigated (100-2,000) (Figure S1).  However, at a concentration 237 
factor of 2,000 some loss of chiral recognition was found for several analytes, thus a pre-238 
concentration factor of 1,000 was selected for stream water.   239 
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Signal suppression during ESI was in the range 20-98 % and 7-96 % for septic tank effluent and 240 
stream water, respectively (Table 1).  Highest suppression was observed for those analytes with the 241 
least interaction with the chiral stationary phase (i.e., shortest retention time).  For example, all 242 
analytes with a retention time <10 min (methylparaben, paracetamol, carbamazepine, carbamazepine 243 
10,11 epoxide, triclocarban, caffeine and cotinine) exhibited suppression of ≥67 %.  On the other hand 244 
R(-)-fluoxetine, R(-)-citalopram, S(+)-citalopram, S(+)-chlorpheniramine, R(-)-chlorpheniramine all 245 
had retention times >40 min and suppression was ≤40 % (Table 1).  Such levels of signal suppression 246 
are typical for enantioselective LC-MS/MS methods for environmental analysis (Bagnall et al., 2012; 247 
Lopez-Serna et al., 2013; Camacho-Muñoz and Kasprzyk-Hordern, 2015).  It is also important to note 248 
that signal suppression between enantiomers of the same chiral marker can vary substantially.  To 249 
demonstrate, signal suppression of S(+)-fluoxetine in stream water was 70 ± 4 % whereas R(-)-250 
fluoxetine had suppression of 38 ± 6 % (Table 1), highlighting the necessity of incorporating labelled 251 
surrogates for quantitative analysis at the enantiomeric level. 252 
Performance of the overall SPE-enantioselective LC-MS/MS methodology was evaluated by spiking 253 
septic tank effluent and stream water at two concentration levels (i.e., 0.5 and 5 µg L-1 for septic tank 254 
effluent and 0.05 and 0.5 µg L-1 for surface water).  Absolute recovery (i.e., only taking into account 255 
analyte peak area) ranged from 2 % to close to 100 % (Table 1).  Corrected recovery or method 256 
accuracy which accounts for the deuterated surrogate response was 90-110 % with RSDs <10 % for 257 
the majority of analytes studied.  However, both methylparaben and aspartame were out with this 258 
range.  As they were quantified using an alternative deuterated surrogate (caffeine-13C3 and S(+)-259 
fluoxetine-d6, respectively), their analysis can only be considered semi-quantitative.        260 
Septic tank effluent MDLs ranged from <0.001 µg L-1 to ~1 µg L-1 whilst MQLs up to ~3 µg L-1 were 261 
determined (Table 1).  In stream water MDLs and MQLs were approximately 10 times lower due to 262 
the cleaner matrix and greater sample pre-concentration that were applied.  MDLs were in the range 263 
<0.001-0.13 µg L-1 with MQLs being <0.001-0.43 µg L-1 (Table 1).  In stream water, paracetamol had 264 
the greatest MQL.  The sensitivity of the developed SPE-LC-MS/MS methodology is similar to those 265 
previously developed and reported in the literature for wastewaters and surface waters (Bagnall et al., 266 
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2012; Lopez-Serna et al., 2013; Camacho-Muñoz and Kasprzyk-Hordern, 2015) (Table 2).  Other than 267 
being the first enantioselective method for the determination of anthropogenic markers in septic tank 268 
effluent, the developed stereoselective LC-MS/MS method reports the greatest number of analytes in 269 
a run time ≤60 min (Table 2).  Methods which do offer multi-residue enantioseparations (e.g., ≥5 270 
analyte classes) often require run times ≥100 min (Camacho-Muñoz and Kasprzyk-Hordern, 2015; 271 
Camacho-Muñoz and Kasprzyk-Hordern, 2016).  The ability to offer simultaneous determination of 272 
achiral anthropogenic markers (caffeine, paracetamol, etc) within the same methodology is a further 273 
advantage.          274 
3.3. Anthropogenic marker stability under sample transport and storage conditions  275 
An important consideration during development of new analytical methods is sample collection and 276 
storage.  This is because errors associated with sampling can outweigh those associated with the 277 
analytical method itself (Ort et al., 2010).  Grab sampling was adopted in this study to give an insight 278 
into anthropogenic marker occurrence and concentration in septic tank effluents and surrounding 279 
surface waters.  However, a limitation of active sampling is the possibility for in-sample degradation 280 
or transformation of anthropogenic markers during sample transport and storage prior to processing.     281 
Analyte stability was assessed in septic tank effluent and stream waters stored at both 18 ˚C and 4 ˚C, 282 
respectively.  Results showed the studied anthropogenic markers were more stable in septic tank 283 
effluent than in stream water kept at both 18 ˚C and 4 ˚C (Figure S2; Figure 3).  In septic tank effluent 284 
only aspartame fell below 75 % of its initial concentration after 48 h storage at 18 ˚C (Figure S2).  On 285 
the other hand, methylparaben, carbamazepine 10,11 epoxide, triclocarban, aspartame, S(+)-286 
amphetamine, S(+)-fluoxetine and R(-)-fluoxetine all fell below 75 % of their starting concentration 287 
under equivalent conditions in stream water (Figure S2).  The difference in stability between the two 288 
matrices could be linked with the aerobic (stream) and anaerobic (septic tank) bacterial species 289 
present.  Degradation of amphetamine in stream water was found to be stereoselective in nature due to 290 
the preferential degradation of S(+)-amphetamine over R(-)-amphetamine (Bagnall et al., 2013).  An 291 
initial racemic EF of 0.5 changed to 0.1 after 48 h storage.  Stereoselective change to amphetamine 292 
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has previously been observed in river water microcosms leading to the enrichment of R(-)-293 
amphetamine (Bagnall et al., 2013).   294 
Stability of anthropogenic markers was improved in both samples matrices by storing at 4 ˚C (Figure 295 
3).  These findings suggest anthropogenic marker losses during storage were biological in nature and 296 
in agreement with previous studies (Hillebrand et al., 2013; Petrie et al., 2017).  In samples stored at 4 297 
˚C for 24 h only carbamazepine 10,11 epoxide and triclocarban degraded by ≥25 % in stream water 298 
(Figure 3B).  At 4 ˚C carbamazepine 10,11 epoxide was found to be stable over 6 h.  However, with 299 
practical considerations in mind a threshold of 24 h (whilst being kept at 4 ˚C) was set for the 300 
transport and processing of all samples.  Under these conditions all analytes were considered stable in 301 
septic tank effluent (Figure 3A).  Furthermore, no enantioselective change to chiral markers was 302 
observed in effluent or stream water stored at 4 ˚C for ≤24 h.         303 
3.4. Application to septic tank effluents 304 
Effluents collected from septic tanks found 10 of the studied anthropogenic chemicals were detected 305 
at least once (Figure 4).  Effluent concentrations ranged from 0.07 µg L-1 for salbutamol-E1 to 1,600 306 
µg L-1 for paracetamol.  Prescription drugs showed greater spatial variation in terms of detection and 307 
concentration than observed in communal wastewater (Baker and Kasprzyk-Hordern et al., 2013; 308 
Petrie et al., 2015).  This is to be expected due to the low number of people which contribute to 309 
individual septic tanks.  Consequently, where detected, prescription drugs were present at 310 
comparatively greater levels than communal wastewaters.   311 
The prescription drug found at the highest concentration was the anti-depressant citalopram.  R(-)-312 
citalopram and S(+)-citalopram were found in one of the studied effluents at 5.1 and 2.1 µg L-1, 313 
respectively (Figure 4).  These concentrations are >20 times greater than previously reported in 314 
communal wastewaters in the UK (Evans et al., 2015; Petrie et al., 2016b).  The EF of citalopram is 315 
0.3 and is typical for that expected in wastewater due to enantioselective metabolism in the body.  The 316 
EF of other chiral drugs determined at the enantiomeric level in effluents (propranolol EF=0.40, 317 
atenolol EF=0.48 and 0.49, fluoxetine EF=0.58 and salbutamol EF=0.37 and 0.50) are typical of that 318 
previously observed in municipal wastewaters following consumption and excretion (Lopez-Serna et 319 
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al., 2013; Evans et al., 2015).  To the authors knowledge chlorpheniramine has not been investigated 320 
at the enantiomeric level in wastewater before.  Septic tank effluent (n=1) was found to have an 321 
enrichment of R(-)-chlorpheniramine (0.10 µg L-1 vs. 0.073 µg L-1 for S(+)-chlorpheniramine) and a 322 
corresponding EF of 0.4.  This is contrary to pharmacokinetic studies whereby the S(+)-enantiomer is 323 
cleared more slowly than the R(-)-enantiomer resulting in an EF >0.5 in urine (chlorpheniramine is 324 
administered as a racemic mixture) (Tung Hiep et al., 1998; Yasuda et al., 2002).  However, 325 
stereoselective degradation could occur within the septic tank resulting in the enrichment of the R(-)-326 
enantiomer in effluent.  Further investigation would be required to verify this hypothesis.                   327 
It is important to consider which anthropogenic markers can be used as indicators of rural surface 328 
water contamination by septic tanks.  Three of the studied analytes were detected in >10 effluents and 329 
at high concentration.  Cotinine, the metabolite of nicotine (n=12), was found in concentrations 330 
ranging from 0.14 µg L-1 to 21 µg L-1 and paracetamol (n=14) from 4.8 µg L-1 to 1,600 µg L-1 (Figure 331 
4).  However, caffeine (n=15) was determined in all samples analyzed ranging from 4.2-396 µg L-1.  332 
The hydrophilic nature of caffeine (log KOW -0.1) and resultant mobility in water, as well as its 333 
ubiquity in septic tank effluent make it a good indicator compound of septic tank discharge in rural 334 
surface waters.  Our findings are in agreement with previous studies which have proposed caffeine as 335 
an indicator of wastewater discharge (Buerge et al., 2003; Potera, 2012), including septic tank systems 336 
(Richards et al., 2017).          337 
3.5. Surface water quality 338 
Surface waters were collected from two rural streams (n=11) to give insight into contamination by 339 
anthropogenic markers originating from septic tanks.  In total 7 of the studied analytes were detected 340 
at least once (paracetamol, carbamazepine, carbamazepine 10,11 epoxide, cotinine, caffeine, 341 
amphetamine and atenolol).  Interestingly, caffeine was detected in all stream water samples and was 342 
generally <0.5 µg L-1 (Table 3).  Such levels are considerably lower than those observed in septic tank 343 
effluents due to further degradation (e.g., in a soak away) and dilution within the stream itself.  344 
Caffeine concentrations determined in river waters (impacted by both septic tanks and communal 345 
WWTPs) were 0.11-0.23 µg L-1 (Table 1).  Prescription drugs detected in stream water included the 346 
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anti-epileptic carbamazepine and carbamazepine 10,11 epoxide, and the beta-blocker atenolol.  These 347 
were <0.02 µg L-1 where quantifiable and in similar levels to that observed in the main river which is 348 
impacted by both septic tank discharges and WWTP effluent.          349 
The most notable finding from collected stream waters was the level of anthropogenic markers found 350 
in sample 2 (Figure 1).  This stream sampling site was directly after passing adjacent to several 351 
households and has low flow.  Upon collection of this sample it had high turbidity and was 352 
malodorous, indicating contamination with untreated wastewater.  In this sample paracetamol, 353 
cotinine and caffeine were present at 1,100 µg L-1, 31 µg L-1 and 200 µg L-1, respectively (Table 3).  354 
Such concentrations are similar to those found in septic tank effluent (Figure 4), and considerably 355 
greater than previously observed in UK surface waters.  To demonstrate, the highest previously 356 
reported concentrations of paracetamol and caffeine in UK surface water is ~2 µg L-1 (Kasprzyk-357 
Hordern et al., 2008; Baker and Kasprzyk-Hordern, 2013).  Furthermore, S(+)-amphetamine and R(-)-358 
amphetamine were present at 0.20 and 0.27 µg L-1, respectively (Table 1).  These concentrations 359 
correspond to an EF of 0.43 which is typical of that found in raw wastewater in the UK (Castrignanò 360 
et al., 2016; Castrignanò et al., 2018).  Findings indicate the direct discharge of septic tank effluent (or 361 
untreated wastewater) to surface water, demonstrating the advantage of undertaking analysis at the 362 
enantiomeric level.  As a limited number of samples were collected in this study to demonstrate the 363 
methods application, a more detailed investigation is now needed to better appreciate the impact of 364 
septic tanks to surrounding surface water quality.              365 
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4. Conclusion 366 
A new multi-residue enantioselective method was successfully developed for anthropogenic markers 367 
in septic tank effluent and rural surface water for the first time.  The method was adequately sensitive 368 
for 16 achiral and chiral markers within a run time of 55 min.  Storage of samples at 4 ˚C was found 369 
to be sufficient for stabilising the majority of anthropogenic markers in septic tank effluent and 370 
surface water for 24 h.  Application of the new methodology revealed the presence of some 371 
anthropogenic markers at high concentration in both septic tank effluents and surrounding surface 372 
waters.  In rural surface water paracetamol was determined at a maximum concentration of 1,100 µg 373 
L-1 which is indicative of untreated wastewater discharge.  Therefore, further application of the 374 
method is needed to better appreciate the environmental risk of septic tanks to surface water quality.  375 
Facilitating the simultaneous analysis of both achiral and chiral compounds at the enantiomeric level 376 
will enable a better understanding of their transport, fate and possible effects in the environment.    377 
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Figure 1.  Area studied in North East Scotland showing septic tank and stream sampling 
locations within sub-catchment A and B, respectively.  Sampling locations on the main river also 
identified.   
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Figure 2. Multiple reaction monitoring enantioselective LC-MS/MS chromatograms of studied 
anthropogenic markers spiked in stream water at 0.05 µg L-1 (paracetamol and aspartame were 
spiked at 0.5 µg L-1). Key: MDMA, 3,4-methylenedioxy-methamphetamine; E1, enantiomer 1; 
E2, enantiomer 2 
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 Figure 3. Stability of anthropogenic markers in septic tank effluent (A) and stream water (B) 
stored in polypropylene bottles stored at 4 ˚C in the dark (n=3). Key: MDMA, 3,4-
methylenedioxy-methamphetamine; E1, enantiomer 1; E2, enantiomer 2 
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 Figure 4. Anthropogenic markers determined in septic tank effluents and their concentration. 
Note: numbers in brackets represent the number of samples the anthropogenic marker was 
found in (from n=15 effluents profiled).  Each effluent is represented by a different graphical 
marker. Key: E1, enantiomer 1; E2, enantiomer 2  
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Table 1. Method performance data for studied anthropogenic markers in septic tank effluent and stream water (n=3) 
Anthropogenic marker 
class Anthropogenic marker 
Recovery from effluent (%) Recovery from stream water (%) 
Signal suppression (%) Effluent Stream water 0.5 µg L-1 5 µg L-1 0.05 µg L-1 0.5 µg L-1 
Absolute Corrected Absolute Corrected Absolute Corrected Absolute Corrected Effluent Stream MDL (µg L-1) 
MQL 
(µg L-1) 
MDL 
(µg L-1) 
MQL 
(µg L-1) 
Preservative Methylparaben 2±0 42±2 2±0 34±1 7±1 48±1 9±1 20±1 98±0 95±0 0.084 0.28 0.002 0.0065 
Analgesic Paracetamol - - 5±2 95±15 - - 2±0 107±0 92±0 96±0 0.85 2.8 0.13 0.43 
Anti-epileptic Carbamazepine 2±0 103±7 2±0 97±2 19±1 107±1 23±4 111±4 98±0 84±1 0.075 0.25 0.0007 0.0024 
 Carbamazepine 10,11 epoxide 5±1 79±5 6±0 74±5 41±2 94±2 45±2 97±2 96±0 67±1 0.0059 0.020 0.0001 0.0002 
Anti-bacterial Triclocarban 3±1 111±29 4±1 102±5 36±9 117±9 35±1 111±1 93±0 71±2 0.081 0.27 0.0008 0.0028 
Beta-antagonist Salbutamol E1 50±5 102±5 51±2 106±4 72±5 105±5 75±4 115±4 53±1 26±3 0.0016 0.0049 0.0001 0.0003 
 Salbutamol E2 31±2 96±4 34±1 107±4 72±5 106±5 77±5 118±5 74±1 19±4 0.0025 0.0077 0.0001 0.0003 
Sweetener Aspartame - - 33±2 113±2 - - 27±1 94±1 64±1 64±7 0.87 2.9 0.099 0.33 
Stimulant and metabolite Cotinine 5±0 91±1 2±1 100±14 16±2 117±2 23±4 105±4 82±1 76±0 0.0089 0.030 0.0002 0.0005 
 Caffeine 31±9 93±4 18±8 98±6 20±4 97±5 22±7 94±7 91±3 80±9 0.0012 0.0041 0.0001 0.0005 
 S(+)-amphetamine 24±2 101±2 23±3 108±2 45±4 109±4 46±3 109±3 78±2 60±9 0.0034 0.011 0.0002 0.0006 
 R(-)-amphetamine 40±1 106±1 41±1 113±5 45±4 98±4 51±4 110±4 61±1 58±11 0.0020 0.0061 0.0002 0.0005 
 R/S(±)-MDMA 69±2 118±3 67±1 106±2 89±6 83±36 90±3 110±3 40±2 32±3 0.0044 0.015 0.0003 0.001 
Beta-blocker S(-)-propranolol 28±3 101±2 27±1 98±2 94±6 101±7 87±5 108±5 74±1 23±1 0.054 0.18 0.0017 0.0056 
 R(+)-propranolol 36±1 99±4 38±1 108±1 100±8 106±8 95±3 113±3 60±2 17±4 0.040 0.14 0.0015 0.0051 
 S(-)-atenolol 49±3 110±10 48±2 107±2 94±8 115±8 89±2 112±2 61±1 48±3 0.0004 0.0010 0.0001 0.0003 
 R(+)-atenolol 94±2 110±4 99±2 107±4 116±8 101±8 110±4 110±4 44±2 26±3 0.0002 0.0005 0.0001 0.0003 
Anti-depressant S(+)-fluoxetine 29±1 104±3 31±1 107±3 34±3 107±3 37±2 114±2 66±0 70±4 0.0050 0.017 0.0042 0.14 
 R(-)-fluoxetine 53±3 104±4 59±1 106±3 66±4 104±4 61±3 109±3 40±1 38±6 0.0027 0.0090 0.0002 0.0008 
 R(-)-citalopram 66±2 110±3 68±1 111±4 93±2 101±2 92±4 102±4 30±0 18±3 0.023 0.075 0.0016 0.0054 
 S(+)-citalopram 70±3 116±4 76±1 111±7 96±5 92±6 96±2 106±2 20±2 16±0 0.021 0.069 0.0016 0.0052 
Anti-histamine S(+)-chlorpheniramine 78±1 104±1 84±1 104±1 102±5 108±5 102±4 110±4 20±4 7±7 0.019 0.062 0.0015 0.0049 
 R(-)-chlorpheniramine 85±2 104±2 90±1 111±3 99±7 99±7 107±5 113±6 20±4 7±5 0.017 0.057 0.0015 0.0049 
Key: MDL, method detection limit; MQL, method quantitation limit; MDMA, 3,4-methylenedioxy-methamphetamine; E1, enantiomer 1; E2, enantiomer 2 
 
  
Table 2.  Enantioselective LC-MS/MS methods validated for the determination of anthropogenic markers in wastewaters and surface waters 
Anthropogenic markers Sample type + preparation Chromatographic column Mobile phase conditions 
Run time 
(min) 
MS 
detector 
Enantiomer 
RS 
Method 
recovery (%) 
MDL  
(µg L-1) Reference 
Aminorex, carboxyibuprofen, cephalexin, 
chloramphenicol, dechloroethylifosfamide, O-
desmethylnaproxen, 10,11-dihydro-10-hydroxy 
carbamazepine, dihydroketoprofen, florfenicol, 
griseofuvlin, 2-hydroxyibuprofen, ibuprofen, ifosfamide, 
indoprofen, ketoprofen, naproxen, phenylpropionic acid, 
praziquantel & tetramisole 
River water (200 mL), wastewater effluent 
(100 mL) filtered (0.7 µm) and Oasis HLB-
MAX SPE. Reconstituted in 0.5 mL mobile 
phase 
Chirobiotic T® 250 x 
4.6 mm, I.D. 5 µm 
@ 25 °C 
10 mM ammonium acetate in 
water (pH 4.2): methanol 
(70:30, v/v) @ 0.08 mL min-1 
150 QqQ 0.4-0.9 8-127 0.0001-1.3 
Camacho-
Muñoz and 
Kasprzyk-
Hordern, 
2017 
Omeprazole*, lansoprazole*, pantoprazole* & 
rabeprazole* 
Wastewater/river water (100 mL) adjusted 
to pH 10 and Cleanert PEP-2 SPE & 
DLLME 
Chiralpak IC® 250 x 
4.6 mm, I.D. 5 µm  
Acetontrile:5 mM 
ammonium acetate in water 
(40:60, v/v) @ 0.6 mL min-1 
30 QqQ >1.5 90-107 0.0007-0.0023 
Zhao et al., 
2016 
Aminorex*, carboxyibuprofen, cephalexin, 
chloramphenicol*, dechloroethylifosfamide, 10,11-
dihydro-10-hydroxy carbamazepine, 
dihydroketoprofen*, fexofenadine*, 2-hydroxyibuprofen, 
ibuprofen*, ifosfamide*, indoprofen, ketoprofen, 
mandelic acid, naproxen*, phenylpropionic acid, 
praziquantel & tetramisole* 
River water (500 mL), wastewater effluent 
(250 mL) filtered (0.7 µm) and Oasis HLB-
MAX SPE. Reconstituted in 0.5 mL mobile 
phase 
Chiral AGP 100 x 2 
mm, I.D. 5 µm @ 
25 °C 
10 mM ammonium acetate in 
water with 1 % acetonitrile 
(pH 6.7) 
100 QqQ ≥0.7 2-158 0.0001-0.34 
Camacho-
Muñoz and 
Kasprzyk-
Hordern, 
2015 
Flumequine, albuterol*, ketoprofen, pindolol*, 
propranolol*, atenolol*, metoprolol*, clenbuterol*, 
sotalol*, timolol*, naproxen & fluoxetine* 
River water (500 mL), wastewater effluent 
(100 mL) filtered (0.7 µm) and Oasis HLB 
SPE. Reconstituted in 0.5 mL mobile phase 
Chirobiotic V® 250 
x 4.6 mm, I.D. 5 µm 
@ 25 °C 
4 mM ammonium acetate + 
0.005 % formic acid in 
methanol @ 0.1 mL min-1 
65 QqQ ≥0.4-1.1 56-116 0.0001-0.011 
Lopez-
Serna et al., 
2013 
Amphetamine*, methamphetamine*, MDMA*, 
propranolol*, atenolol*, metoprolol*, venlafaxine* & 
fluoxetine* 
River water (250 mL), effluent (100 mL) 
filtered (0.7 µm) and Oasis HLB SPE. 
Reconstituted in 0.5 mL mobile phase 
Chirobiotic V® 250 
x 4.6 mm, I.D. 5 µm 
@ 25 °C 
4 mM ammonium acetate + 
0.005 % formic acid in 
methanol @ 0.1 mL min-1 
40 QTOF-MS 0.9-4.7 61-126 
0.0002-
0.023 
Bagnall et 
al., 2012 
Aspartame, caffeine, carbamazepine, carbamazepine 
10,11 epoxide, cotinine, methylparaben, paracetamol, 
triclocarban, amphetamine*, atenolol*, 
chlorpheniramine*, citalopram*, fluoxetine*, MDMA, 
propranolol* & salbutamol* 
River water (250 mL), septic tank effluent 
(25 mL) filtered (0.7 µm) and Oasis HLB 
SPE. Reconstituted in 0.25 mL mobile 
phase 
Chirobiotic V2® 250 
x 2.1 mm, I.D. 5 µm 
@ 15 °C 
1 mM ammonium acetate + 
0.01 % acetic acid in 
methanol @ 0.17 mL min-1 
60 QqQ 1-2.3 20-118 0.0001-0.87 This study 
Key: MS/MS, tandem mass spectrometry; MDL, method detection limit; QqQ, triple quadrupole; SPE, solid phase extraction; NH4OAc, ammonium acetate; 
MeOH, methanol; ACN, acetonitrile; HCOOH, formic acid; CH3COOH, acetic acid; QTOF, quadrupole time of flight; MDMA, 3,4-methylenedioxy-
methamphetamine; *, highlights those separated at the enantiomeric level with RS≥1 
 
  
Table 3.  Concentration of anthropogenic markers detected in studied surface water samples (µg L-1)  
Anthropogenic marker 
Stream water sample River water sample 
Sub-catchment A Sub-catchment B 
1 2 3 4 5 6 7 8 9 10 11 1 2 3 
Paracetamol <MQL 1,100 <MQL <MQL 1.6 <MQL <MQL <MQL 1.0 <MQL <MQL <MQL <MQL <MQL 
Carbamazepine - - 0.0037 - - - 0.011 - - - 0.0091 0.015 0.015 0.012 
Carbamazepine 10,11 epoxide - - 0.0056 - - - <MQL - - - <MQL 0.018 0.013 0.011 
Cotinine - 31 0.0063 <MQL 0.013 0.011 0.0015 0.0025 0.011 0.00070 0.012 0.0042 0.0025 0.0011 
Caffeine 0.036 200 0.16 0.038 0.49 0.17 0.29 0.17 0.37 0.045 0.42 0.19 0.23 0.11 
S(+)-amphetamine - 0.20 - - - - - - - - - - - - 
R(-)-amphetamine - 0.27 - - - - - - - - - - - - 
S(-)-atenolol - - - - 0.015 - - 0.0054 - - 0.020 0.0056 0.0056 0.0039 
R(+)-atenolol - - - - 0.015 - - 0.0043 - - 0.019 0.0045 0.0049 0.0034 
Key: -, below method detection limit; <MQL, below method quantitation limit 
Note: Sample locations correspond to those outlined in the catchment map in Figure 1.  All other anthropogenic markers were not detected in any of the 
collected surface water samples 
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Figure S1. Impact of SPE concentration factor on analyte response for septic tank effluent (A) 14 
and stream water (B). Key: MDMA, 3,4-methylenedioxy-methamphetamine; E1, enantiomer 1; 15 
E2, enantiomer 2 16 
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Figure S2. Stability of anthropogenic markers in septic tank effluent (A) and stream water (B) 19 
stored in polypropylene bottles stored at 18 ˚C in the dark. Key: MDMA, 3,4-methylenedioxy-20 
methamphetamine; E1, enantiomer 1; E2, enantiomer 2 21 
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Table S1.  MS/MS method detail for studied anthropogenic markers 
Class of anthropogenic 
marker Anthropogenic marker 
Fragmentor 
(V) 
MRM 1 
(quantifier) 
Collision 
energy (eV) 
MRM 2 
(qualifier) 
Collision 
energy (eV) Corresponding internal standard 
Preservative Methylparaben 90 150.9>92.0 20 150.9>136.0 10 Caffeine-13C3 
Analgesic Paracetamol 100 151.9>110.0 10 151.9>65.1 30 Paracetamol-d4 
Anti-epileptic Carbamazepine 130 236.8>178.9 40 236.8>193.9 20 Carbamazepine-d10 
 Carbamazepine 10,11 epoxide 90 252.8>179.9 30 252.8>210.0 10 Carbamazepine 10,11 epoxide-d10 
Anti-bacterial Triclocarban 110 312.5>159.7 10 312.5>125.6 20 Triclocarban-d3 
Beta-antagonist Salbutamol  90 239.9>147.9 10 239.9>165.9 10 Salbutamol-d3 
Sweetener Aspartame 90 295.0>119.9 20 295.0>180.0 30 S(+)-fluoxetine-d6 
Stimulant and metabolite Cotinine 90 176.9>80.0 20 176.9>98.0 20 Cotinine-d3 
 Caffeine 90 194.9>110.0 20 194.9>138.0 18 Caffeine-13C3 
 R/S(±)-amphetamine 70 135.8>90.9 20 135.8>65.0 40 R/S(±)-amphetamine-d11 
 R/S(±)-MDMA 90 193.9>162.8 10 193.9>104.8 30 R/S(±)-MDMA-d5 
Beta-blocker R/S(±)-propranolol 110 259.9>115.9 30 259.9>182.9 20 R/S(±)-propranolol-d7 
 R/S(±)-atenolol 90 267.0>145.0 30 267.0>190.0 20 R/S(±)-atenolol-d7 
Anti-depressant R/S(±)-fluoxetine 90 309.8>44.0 10 309.8>147.7 5 R/S(±)-fluoxetine-d6 
 R/S(±)-citalopram 130 325.0>108.9 30 325.0>262.0 20 R/S(±)-citalopram-d6 
Anti-histamine R/S(±)-chlorpheniramine 90 274.9>229.9 10 274.9>166.8 40 R/S(±)-chlorpheniramine-d6 
Labelled surrogates Caffeine-13C3 90 198.0>139.9 20 - - - 
 Paracetamol-d4 90 155.9>114.0 20 - - - 
 Carbamazepine-d10 130 246.9>204.1 20 - - - 
 Carbamazepine 10,11 epoxide-d10 90 263.0>189.9 30 - - - 
 Triclocarban-d3 110 318.9>161.9 10 - - - 
 Salbutamol-d3 90 243.0>150.9 10 - - - 
 R/S(±)-amphetamine-d11 70 147.0>98.0 20 - - - 
 R/S(±)-MDMA-d5 90 199.0>164.9 10 - - - 
 R/S(±)-propranolol-d7 110 267.0>188.8 15 - - - 
 Cotinine-d3 90 180.0>80.0 30 - - - 
 R/S(±)-fluoxetine-d6 90 316.0>154.0 2 - - - 
 R/S(±)-atenolol-d7 100 274.1>145.0 30 - - - 
 R/S(±)-citalopram-d6 130 331.0>109.0 30 - - - 
 R/S(±)-chlorpheniramine-d6 100 281.0>229.9 10 - - - 
Key: MRM, multiple reaction monitoring; MDMA, 3,4-methylenedioxy-methamphetamine; E1, enantiomer 1; E2, enantiomer 2
Table S2. Instrument performance information for studied anthropogenic markers 
Class of anthropogenic 
marker Anthropogenic marker Rt (min) 
Linearity IDLS/N (µg L-1) IQLS/N (µg L-1) Range (µg L-1) r2 
Preservative Methylparaben 4.78±0.02 0.50-500 0.999 0.15 0.50 
Analgesic Paracetamol 4.98±0.03 10-1,000 0.999 3.0 10 
Anti-epileptic Carbamazepine 5.47±0.01 0.50-2,000 0.999 0.15 0.50 
 Carbamazepine 10,11 epoxide 6.06±0.03 0.10-1,000 0.999 0.030 0.10 
Anti-bacterial Triclocarban 6.48±0.03 1.0-500 0.999 0.30 1.00 
Beta-antagonist Salbutamol E1 16.10±0.17 0.25-2,500 0.999 0.080 0.25 
 Salbutamol E2 18.14±0.21 0.25-2,500 0.999 0.080 0.25 
Sweetener Aspartame 20.60±0.78 100-1,000 0.999 30 100 
Stimulant and metabolites Cotinine 5.85±0.03 0.10-1,000 0.999 0.030 0.10 
 Caffeine 6.46±0.03 0.10-1,000 0.999 0.030 0.10 
 S(+)-amphetamine 24.33±0.27 0.25-2,500 0.999 0.080 0.25 
 R(-)-amphetamine 28.04±0.33 0.25-2,500 1.000 0.080 0.25 
 R/S(±)-MDMA 35.77±0.45 1.0-1,000 0.999 0.30 1.0 
Beta-blocker S(-)-propranolol 24.42±0.32 5.0-1,000 0.999 1.5 5.0 
 R(+)-propranolol 27.50±0.35 5.0-1,000 0.999 1.5 5.0 
 S(-)-atenolol 34.75±0.44 0.050-1,000 0.999 0.020 0.050 
 R(+)-atenolol 37.91±0.46 0.050-1,000 0.999 0.020 0.050 
Anti-depressant S(+)-fluoxetine 32.03±0.40 0.50-2,500 0.999 0.15 0.50 
 R(-)-fluoxetine 41.54±0.60 0.50-2,500 0.999 0.15 0.50 
 R(-)-citalopram 45.60±0.77 5.0-1,000 0.999 1.5 5.0 
 S(+)-citalopram 50.93±0.93 5.0-1,000 0.999 1.5 5.0 
Anti-histamine S(+)-chlorpheniramine 42.19±0.76 5.0-1,000 0.999 1.5 5.0 
 R(-)-chlorpheniramine 46.53±0.88 5.0-1,000 0.999 1.5 5.0 
Key: Rt, retention time; IDL, instrument detection limit; IQL, instrument quantitation limit; MDMA, 3,4-methylenedioxy-methamphetamine; E1, enantiomer 
1; E2, enantiomer 2 
Table S3. Inter-day and intra-day precision and accuracy of enantioselective LC-MS/MS method 
Class of anthropogenic 
marker Anthropogenic marker 
Precision (%, expressed as RSD) Accuracy (%) 
Intra-day Inter-day Intra-day Inter-day 
Low Mid High Low Mid High Low Mid High Low Mid High 
Preservative Methylparaben 3.6 0.7 0.5 4.6 0.1 0.3 96.9 99.6 101.1 98.7 99.2 100.1 
Analgesic Paracetamol 3.4 1.8 1.2 3.5 0.8 0.7 95.0 99.7 101.4 94.8 101.5 102.6 
Anti-epileptic Carbamazepine 6.9 4.7 3.1 8.1 1.1 1.7 112.9 110.0 99.9 110.5 106.6 102.4 
 Carbamazepine 10,11 epoxide 0.6 2.4 1.8 1.2 0.2 0.6 92.4 99.7 97.9 93.2 99.5 97.4 
Anti-bacterial Triclocarban 3.8 3.2 4.0 0.9 3.2 4.0 92.9 96.6 92.7 90.8 96.6 92.7 
Beta-antagonist Salbutamol E1 0.8 2.9 1.8 0.3 1.0 0.7 96.7 95.2 104.2 95.6 96.9 102.7 
 Salbutamol E2 1.5 0.4 4.2 1.6 3.0 2.9 104.4 106.1 94.9 106.0 109.7 93.4 
Sweetener Aspartame 3.2 1.6 0.6 4.9 3.2 1.5 101.6 89.4 97.8 103.7 91.9 98.7 
Stimulant and metabolites Cotinine 0.6 2.4 1.8 1.2 0.2 0.6 92.4 99.7 97.9 93.2 99.5 97.4 
 Caffeine 3.2 1.3 1.1 1.3 0.6 0.1 89.0 100.8 99.5 87.9 98.7 100.1 
 S(+)-amphetamine 2.8 3.3 0.2 0.8 0.3 0.2 93.3 98.8 101.4 93.4 100.7 99.4 
 R(-)-amphetamine 2.2 1.8 0.4 1.1 3.2 2.3 93.0 98.9 97.6 94.6 101.0 99.0 
 R/S(±)-MDMA 1.5 5.3 0.1 0.4 2.3 1.8 94.1 98.8 96.0 95.0 98.7 97.1 
Beta-blocker S(-)-propranolol 3.2 0.8 0.4 1.1 0.7 0.2 98.2 95.4 99.2 98.7 95.6 99.6 
 R(+)-propranolol 4.4 2.2 1.4 1.1 0.5 1.4 91.3 90.6 98.3 85.6 93.4 98.3 
 S(-)-atenolol 1.6 1.1 2.0 1.4 1.4 2.3 95.8 102.3 97.6 94.8 99.7 102.0 
 R(+)-atenolol 3.3 1.4 1.7 1.8 2.4 1.1 93.8 98.3 106.0 92.8 103.3 103.8 
Anti-depressant S(+)-fluoxetine 0.9 2.0 2.1 0.9 1.8 2.0 91.5 100.7 99.0 91.5 100.6 99.7 
 R(-)-fluoxetine 2.3 1.8 1.2 2.8 3.1 1.3 90.4 99.6 101.0 92.4 102.3 102.4 
 R(-)-citalopram 1.3 2.0 1.1 1.1 1.5 1.1 105.9 96.1 97.2 104.6 94.3 97.2 
 S(+)-citalopram 1.9 2.0 0.5 1.5 1.3 0.1 102.7 109.6 107.3 100.9 109.0 106.7 
Anti-histamine S(+)-chlorpheniramine 0.9 1.3 0.3 0.9 0.6 0.3 99.4 107.6 110.0 98.9 106.8 110.0 
 R(-)-chlorpheniramine 2.0 1.0 0.8 0.8 1.7 0.9 94.2 98.4 97.7 95.7 99.7 98.3 
Key: MDMA, 3,4-methylenedioxy-methamphetamine; E1, enantiomer 1; E2, enantiomer 2; RSD, relative standard deviation; Low, mid and high 
concentration levels were 0.010, 0.10 and 0.50 ng mL-1, respectively.  For aspartame the concentration levels were 0.010, 0.10 and 0.50 ng mL-1  
